Skip to main content
. 2022 Mar 29;322(6):R467–R485. doi: 10.1152/ajpregu.00017.2022

Table 3.

Metabolic parameters assessed via Promethion multiplexed phenotyping system, body composition changes assessed by NMR, estimates of calories committed to growth, and total unaccounted calories (hypothesized to be a metric of anaerobic energy expenditure)

End Point 5L0D + DOCA
(n = 9)
2920x + DOCA
(n = 9)
P Value
FFM Fat Diet
Body mass, g
 (uncorrected) 25.35 ± 0.56 26.39 ± 0.78 0.30
Fat-free mass (FFM), g
 (uncorrected) 19.22 ± 0.44 19.40 ± 0.47 0.79
Fat mass, g
 (uncorrected) 5.86 ± 0.11 6.01 ± 0.25 0.59
Light phase heat, kcal/h
 (uncorrected) 0.394 ± 0.009 0.374 ± 0.012 0.19
 (EMM) 0.395 ± 0.007 0.372 ± 0.007 <0.01 1.00 0.04
Dark phase heat, kcal/h
 (uncorrected) 0.479 ± 0.011 0.0472 ± 0.014 0.69
 (EMM) 0.480 ± 0.011 0.471 ± 0.011 0.01 0.85 0.53
Locomotor activity, m/d
 (uncorrected) 374.25 ± 30.17 342.46 ± 33.94 0.49
 (EMM) 371.21 ± 29.05 345.50 ± 29.05 0.10 0.07 0.54
Food intake, g/d
 (uncorrected) 4.94 ± 0.33 3.65 ± 0.23 0.01
 (EMM) 4.96 ± 0.28 3.62 ± 0.28 0.14 0.96 <0.01
Meals per phase, n
 Light phase 25.6 ± 3.0 23.6 ± 3.0
 Dark phase 39.9 ± 1.5 34.3 ± 3.1
Total fluid intake, mL/d
 (uncorrected) 18.50 ± 1.21 9.80 ± 1.56 <0.01
 (EMM) 18.46 ± 1.26 9.85 ± 1.26 0.04 0.16 <0.01
Total Na intake, mEq/d
 (uncorrected) 1.28 ± 0.14 0.67 ± 0.13 0.01
 (EMM) 1.30 ± 0.13 0.65 ± 0.13 0.08 0.79 <0.01
Δ Fat mass, Mon–Fri
 (grams) −0.57 ± 0.12 −1.05 ± 0.13 0.01
 (kcal equivalent @ 9 kcal/g) −5.15 ± 1.10 −9.43 ± 1.13
Δ Fat-free mass, Mon–Fri
 (grams) 0.24 ± 0.10 0.08 ± 0.11 0.28
 (kcal equivalent @ 4 kcal/g) 2.18 ± 0.87 0.75 ± 0.95
Calories to growth, Mon–Fri
 (kcal) −4.18 ± 1.21 −9.10 ± 1.17 0.01
Calories consumed, Mon–Fri
 (kcal) 160.71 ± 9.84 69.85 ± 8.48 <0.01
Calories absorbed, Mon–Fri
 (digestive efficiency from Fig. 2D; %) 81.0 ± 0.8 86.6 ± 0.8 <0.01
 (kcal) 130.18 ± 7.97 60.49 ± 7.35 <0.01
Total aerobic expenditure, Mon–Fri
 (kcal) 40.38 ± 0.96 39.07 ± 1.08 0.38
Unaccounted energy, Mon–Fri
 (kcal) 93.97 ± 7.58 30.53 ± 7.03 <0.01
 (% intake) 72 ± 2 38 ± 14 0.03

Data presented as means ± SE. Data analyzed by t test when uncorrected for covariates, or by GLM when correcting for fat-free mass (FFM) and fat mass. Estimated marginal means (EMM) ± SE values are reported after consideration of covariates at FFM = 19.31 g, fat mass = 5.93 g. DOCA, deoxycorticosterone acetate. GLM, generalized linear model.